Table 1.
Overall description of patients and tumor characteristics.
| Variable | Overall N = 186 |
Missings (%) |
|---|---|---|
| Age at surgery, years (median [IQR]) | 66.63 [58.30; 73.50] | 0 (0) |
| Sex = Female (%) | 36 (19.4) | 0 (0) |
| Performance Status = 1 (%) | 22 (11.8) | 0 (0) |
| Alcoholic liver cirrhosis (%) | 35 (18.8) | 0 (0) |
| HBV-related liver cirrhosis (%) | 39 (21.0) | 0 (0) |
| HCV-related liver cirrhosis (%) | 103 (55.4) | 0 (0) |
| Child Pugh class B (%) | 22 (13.8) | 18 (9.7%) |
| MELD score, points (median [IQR]) | 8.00 [7.00; 10.00] | 0 (0) |
| ALBI score, points (median [IQR]) | −2.50 [−2.80; −2.18] | 1 (0.5) |
| ALBI grade 1 (%) | 76 (41.1) | 1 (0.5) |
| ALBI grade 2 (%) | 102 (55.1) | 1 (0.5) |
| ALBI grade 3 (%) | 7 (3.8) | 1 (0.5) |
| log10αFP, ng/mL (median [IQR]) | 1.17 [0.70; 0.98] | 25 (13.4) |
| Multinodular tumor (%) | 49 (26.3) | 0 (0) |
| Maximum tumor size, mm (median [IQR]) | 35.00 [24.00; 51.50] | 0 (0) |
| Satellitosis (%) | 37 (19.9) | 0 (0) |
| BCLC = 0 (%) | 28 (15.1) | 0 (0) |
| BCLC = A (%) | 90 (48.4) | 0 (0) |
| BCLC = B (%) | 57 (30.6) | 0 (0) |
| BCLC = C (%) | 11 (5.9) | 0 (0) |
| LI-RADS = 3 (%) | 17 (9.1) | 0 (0) |
| LI-RADS = 4 (%) | 36 (19.4) | 0 (0) |
| LI-RADS = 5 (%) | 133 (71.5) | 0 (0) |
| Clavien–Dindo Score = 0 (%) | 106 (57.6) | 2 (1.1) |
| Clavien–Dindo Score = 1 (%) | 16 (8.7) | 2 (1.1) |
| Clavien–Dindo Score = 2 (%) | 30 (16.3) | 2 (1.1) |
| Clavien–Dindo Score = 3a (%) | 7 (3.8) | 2 (1.1) |
| Clavien–Dindo Score = 3b (%) | 3 (1.6) | 2 (1.1) |
| Clavien–Dindo Score = 4a (%) | 10 (5.4) | 2 (1.1) |
| Clavien–Dindo Score = 4b (%) | 7 (3.8) | 2 (1.1) |
| Clavien–Dindo Score = 5 (%) | 4 (2.2) | 2 (1.1) |
| Length of stay (median [IQR]) | 9.00 [7.00; 15.00] | 0 (0) |
| Tumor grading = 1 (%) | 17 (9.3) | 3 (1.6) |
| Tumor grading = 2 (%) | 96 (52.5) | 3 (1.6) |
| Tumor grading = 3 (%) | 70 (38.3) | 3 (1.6) |
| Microvascular invasion (%) | 76 (36.2) | 1 (1.1) |
| Satellitosis (%) | 39 (21.1) | 1 (0.5) |
| Capsule infiltration (%) | 43 (23.2) | 1 (0.5) |
| R0 resection (%) | 153 (86.9) | 10 (5.4) |
| Tumor recurrence (%) | 112 (60.2) | 0 (0) |
| Liver transplant after resection (%) | 23 (12.5) | 2 (1.1) |
| Patient death (%) | 109 (58.6) | 0 (0) |
| Cause of Patient death = Cirrhosis (%) | 29 (26.6) | 0 (0) |
| Cause of Patient death = Tumor (%) | 55 (50.5) | 0 (0) |
| Cause of Patient death = Other (%) | 25 (22.9) | 0 (0) |
Abbreviations: MELD, Model for End Stage Liver Disease; HBV, Hepatitis B Virus; HCV, Hepatitis C Virus; ALBI, Albumin-Bilirubin; αFP, alpha-fetoprotein; BCLC, Barcelona Clinic for Liver Cancer; LI-RADS, Liver Imaging Reporting and Data System.